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During multiple sclerosis (MS), the main axon cystoskeleton proteins,
neurofilaments (NF), are altered, and their release into the cerebrospinal fluid
correlates with disease severity. The role of NF in the extraaxonal location is
unknown. Therefore, we tested whether synthetic peptides corresponding to the
tubulin-binding site (TBS) sequence identified on light NF chain (NFL-TBS.40–63)
and keratin (KER-TBS.1–24), which could be released during MS, modulate
remyelination in vitro. Biotinylated NFL-TBS.40–63, NFL-Scramble2, and KER-
TBS.1–54 (1–100 μM, 24 hr) were added to rat oligodendrocyte (OL) and astrocyte
(AS) cultures, grown in chemically defined medium. Proliferation and differentiation
were characterized by using specific antibodies (A2B5, CNP, MBP, GFAP) and
compared with untreated cultures. Lysophosphatidyl choline (LPC; 2 × 10–5 M) was
used to induce OL death and to test the effects of TBS peptides under these
conditions. NFL-TBS.40–63 significantly increased OL differentiation and
maturation, with more CNP+ and MBP+ cells characterized by numerous ramified
processes, along with myelin balls. When OL were challenged with LPC, concomitant
treatment with NFL-TBS.40–63 rescued more than 50% of OL compared with
cultures treated with LPC only. Proliferation of OL progenitors was not affected, nor
were AS proliferation and differentiation. NFL-TBS.40–63 peptide induces specific
effects in vitro, increasing OL differentiation and maturation without altering AS
fate. In addition, it partially protects OL from demyelinating injury. Thus release of
NFL-TBS.40–63 caused by axonal damage in vivo could improve repair through
increased OL differentiation, which is a prerequisite for remyelination.
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